Pawlicki Raymond 4

4 · BIOGEN IDEC INC. · Filed Feb 12, 2013

Form 4

Period: 2013-02-08

SVP, Chief Information Officer

Transactions

Exercise/Conversion
Common Stock
2013-02-09+1,890→ 10,125.711 total
Exercise/Conversion
Restricted Stock Unit
2013-02-09−1,890→ 3,780 total
Exercise: $0.00Exp: 2015-02-09→ Common Stock (1,890 underlying)
Exercise/Conversion
Common Stock
2013-02-08+1,106→ 8,758.711 total
Tax Payment
Common Stock
2013-02-08$164.44/sh−523$86,002→ 8,235.711 total
Tax Payment
Common Stock
2013-02-09$164.44/sh−893$146,845→ 9,232.711 total
Exercise/Conversion
Restricted Stock Unit
2013-02-08−1,106→ 4,003 total
Exercise: $0.00Exp: 2016-02-08→ Common Stock (1,106 underlying)
Other
Restricted Stock Unit
2013-02-08−171→ 3,832 total
Exercise: $0.00Exp: 2016-02-08→ Common Stock (171 underlying)

Footnotes (2)

[F1]The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 150% of the number of shares at target payout. One-fourth of these RSUs are eligible to vest on each of the first four anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen Idec common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the average 60 calendar-day closing stock price ending on the vesting date divided by the average 60 calendar-day closing stock price on the grant date]).
[F2]This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested.

Documents

1 file